Research Design Service: East Midlands
« back

Alzheimer's Society

  Friday, 27 Mar 2020 | Funding Deadline

Alzheimer’s Society project grants are for more established researchers and provide funding for world-class dementia research. Funding is available for up to three years providing budgets for staff salary, consumables and equipment. Applications can be made for research projects which fit within the Alzheimer’s Society funding remit, which is organised into two streams:

  • Biomedical research
  • Care, implementation and public health research

Find out more here

 

Alzheimer’s Society fellowships support researchers across the UK who aim to understand more about the causes of dementia, who are working towards a cure and looking to improving the care of those living with the condition.

The following fellowship and studentship opportunities are available:

  • Senior Fellowships: A Senior Fellowship is for post-doctoral or other successful researchers who wish to build on a number of successful years of dementia research, and who demonstrate the ambition and potential to be a leader in their research field at the end of the award.
  • Junior Fellowships: Junior Fellowships are for post-doctoral researchers who have shown exceptional promise at the start of their research career. Applicants should demonstrate potential to be an independent researcher.
  • Clinician and healthcare professionals training fellowships: Clinician and Healthcare Professional Training Fellowships provide an opportunity for individuals to study for a higher degree with a view to developing a career that combines research and practice.
  • PhD studentships: These provide funding for students wishing to embark on a career in dementia research.

Find out more here

 

The Drug Discovery programme funds research to identify and test drug treatments for Alzheimer's disease and other forms of dementia. Alzheimer's Society welcomes applications that identify and test drug treatments for Alzheimer's disease and other forms of dementia. They are funding a portfolio of studies that look at the preclinical identification, and early and late phase testing of drugs for Alzheimer's disease and vascular dementia.

Deadline for proposals: Midday on 27 March 2020

Find out more here